Literature DB >> 27643442

Different activation signals induce distinct mast cell degranulation strategies.

Nicolas Gaudenzio, Riccardo Sibilano, Thomas Marichal, Philipp Starkl, Laurent L Reber, Nicolas Cenac, Benjamin D McNeil, Xinzhong Dong, Joseph D Hernandez, Ronit Sagi-Eisenberg, Ilan Hammel, Axel Roers, Salvatore Valitutti, Mindy Tsai, Eric Espinosa, Stephen J Galli.   

Abstract

Mast cells (MCs) influence intercellular communication during inflammation by secreting cytoplasmic granules that contain diverse mediators. Here, we have demonstrated that MCs decode different activation stimuli into spatially and temporally distinct patterns of granule secretion. Certain signals, including substance P, the complement anaphylatoxins C3a and C5a, and endothelin 1, induced human MCs rapidly to secrete small and relatively spherical granule structures, a pattern consistent with the secretion of individual granules. Conversely, activating MCs with anti-IgE increased the time partition between signaling and secretion, which was associated with a period of sustained elevation of intracellular calcium and formation of larger and more heterogeneously shaped granule structures that underwent prolonged exteriorization. Pharmacological inhibition of IKK-β during IgE-dependent stimulation strongly reduced the time partition between signaling and secretion, inhibited SNAP23/STX4 complex formation, and switched the degranulation pattern into one that resembled degranulation induced by substance P. IgE-dependent and substance P-dependent activation in vivo also induced different patterns of mouse MC degranulation that were associated with distinct local and systemic pathophysiological responses. These findings show that cytoplasmic granule secretion from MCs that occurs in response to different activating stimuli can exhibit distinct dynamics and features that are associated with distinct patterns of MC-dependent inflammation.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27643442      PMCID: PMC5096814          DOI: 10.1172/JCI85538

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  71 in total

1.  Immunoglobulin E-independent activation of mast cell is mediated by Mrg receptors.

Authors:  Kazuhiko Tatemoto; Yuko Nozaki; Ryoko Tsuda; Shinobu Konno; Keiko Tomura; Masahiro Furuno; Hiroyuki Ogasawara; Koji Edamura; Hideo Takagi; Hiroyuki Iwamura; Masato Noguchi; Takayuki Naito
Journal:  Biochem Biophys Res Commun       Date:  2006-09-08       Impact factor: 3.575

2.  Interleukin-1 is released at sites of human cutaneous allergic reactions.

Authors:  B S Bochner; E N Charlesworth; L M Lichtenstein; C P Derse; S Gillis; C A Dinarello; R P Schleimer
Journal:  J Allergy Clin Immunol       Date:  1990-12       Impact factor: 10.793

3.  BMS-345541 is a highly selective inhibitor of I kappa B kinase that binds at an allosteric site of the enzyme and blocks NF-kappa B-dependent transcription in mice.

Authors:  James R Burke; Mark A Pattoli; Kurt R Gregor; Patrick J Brassil; John F MacMaster; Kim W McIntyre; Xiaoxia Yang; Violetta S Iotzova; Wendy Clarke; Joann Strnad; Yuping Qiu; F Christopher Zusi
Journal:  J Biol Chem       Date:  2002-10-25       Impact factor: 5.157

4.  PMX-53 as a dual CD88 antagonist and an agonist for Mas-related gene 2 (MrgX2) in human mast cells.

Authors:  Hariharan Subramanian; Sakeen W Kashem; Sarah J Collington; Hongchang Qu; John D Lambris; Hydar Ali
Journal:  Mol Pharmacol       Date:  2011-03-11       Impact factor: 4.436

5.  Immunoglobulin E-mediated degranulation of isolated human lung mast cells.

Authors:  A M Dvorak; E S Schulman; S P Peters; D W MacGlashan; H H Newball; R P Schleimer; L M Lichtenstein
Journal:  Lab Invest       Date:  1985-07       Impact factor: 5.662

6.  Mast cells are key promoters of contact allergy that mediate the adjuvant effects of haptens.

Authors:  Anne Dudeck; Jan Dudeck; Julia Scholten; Anke Petzold; Sangeetha Surianarayanan; Anja Köhler; Katrin Peschke; David Vöhringer; Claudia Waskow; Thomas Krieg; Werner Müller; Ari Waisman; Karin Hartmann; Matthias Gunzer; Axel Roers
Journal:  Immunity       Date:  2011-06-24       Impact factor: 31.745

7.  VAMP-8 segregates mast cell-preformed mediator exocytosis from cytokine trafficking pathways.

Authors:  Neeraj Tiwari; Cheng-Chun Wang; Cristiana Brochetta; Gou Ke; Francesca Vita; Zeng Qi; Juan Rivera; Maria Rosa Soranzo; Giuliano Zabucchi; Wanjin Hong; Ulrich Blank
Journal:  Blood       Date:  2008-01-18       Impact factor: 22.113

8.  Mast cell activation contributes to sickle cell pathobiology and pain in mice.

Authors:  Lucile Vincent; Derek Vang; Julia Nguyen; Mihir Gupta; Kathryn Luk; Marna E Ericson; Donald A Simone; Kalpna Gupta
Journal:  Blood       Date:  2013-06-17       Impact factor: 22.113

9.  Human mast cells drive memory CD4+ T cells toward an inflammatory IL-22+ phenotype.

Authors:  Nicolas Gaudenzio; Camille Laurent; Salvatore Valitutti; Eric Espinosa
Journal:  J Allergy Clin Immunol       Date:  2013-03-19       Impact factor: 10.793

10.  Molecular mechanism of mast cell mediated innate defense against endothelin and snake venom sarafotoxin.

Authors:  Lars A Schneider; Susan M Schlenner; Thorsten B Feyerabend; Markus Wunderlin; Hans-Reimer Rodewald
Journal:  J Exp Med       Date:  2007-10-08       Impact factor: 14.307

View more
  94 in total

1.  Involvement of the Negative Feedback of IL-33 Signaling in the Anti-Inflammatory Effect of Electro-acupuncture on Allergic Contact Dermatitis via Targeting MicroRNA-155 in Mast Cells.

Authors:  Zhigang Wang; Tao Yi; Man Long; Fengmin Ding; Lichen Ouyang; Zebin Chen
Journal:  Inflammation       Date:  2018-06       Impact factor: 4.092

2.  Naturally Occurring Missense MRGPRX2 Variants Display Loss of Function Phenotype for Mast Cell Degranulation in Response to Substance P, Hemokinin-1, Human β-Defensin-3, and Icatibant.

Authors:  Ibrahim Alkanfari; Kshitij Gupta; Tahsin Jahan; Hydar Ali
Journal:  J Immunol       Date:  2018-05-23       Impact factor: 5.422

3.  Critical role of C5a in sickle cell disease.

Authors:  Gregory M Vercellotti; Agustin P Dalmasso; Terry R Schaid; Julia Nguyen; Chunsheng Chen; Marna E Ericson; Fuad Abdulla; Trevor Killeen; Margaret A Lindorfer; Ronald P Taylor; John D Belcher
Journal:  Am J Hematol       Date:  2019-01-03       Impact factor: 10.047

4.  Imaging protective mast cells in living mice during severe contact hypersensitivity.

Authors:  Laurent L Reber; Riccardo Sibilano; Philipp Starkl; Axel Roers; Michele A Grimbaldeston; Mindy Tsai; Nicolas Gaudenzio; Stephen J Galli
Journal:  JCI Insight       Date:  2017-05-04

5.  Reply: The complexity of substance P-mediated mast cell activation.

Authors:  Guo-Ping Shi; Ilze Bot; Petri T Kovanen
Journal:  Nat Rev Cardiol       Date:  2017-01-05       Impact factor: 32.419

Review 6.  Recent advances in our understanding of mast cell activation - or should it be mast cell mediator disorders?

Authors:  Theoharis C Theoharides; Irene Tsilioni; Huali Ren
Journal:  Expert Rev Clin Immunol       Date:  2019-04-22       Impact factor: 4.473

7.  How mast cells make decisions.

Authors:  Jörn Karhausen; Soman N Abraham
Journal:  J Clin Invest       Date:  2016-09-19       Impact factor: 14.808

8.  Mas-related G protein coupled receptor-X2: A potential new target for modulating mast cell-mediated allergic and inflammatory diseases.

Authors:  Hydar Ali
Journal:  J Immunobiol       Date:  2016-12-28

9.  Measurement of Exocytosis in Genetically Manipulated Mast Cells.

Authors:  Ofir Klein; Nurit P Azouz; Ronit Sagi-Eisenberg
Journal:  Methods Mol Biol       Date:  2021

10.  Isolation of Peritoneum-derived Mast Cells and Their Functional Characterization with Ca2+-imaging and Degranulation Assays.

Authors:  Volodymyr Tsvilovskyy; Alejandra Solis-Lopez; Kathrin Öhlenschläger; Marc Freichel
Journal:  J Vis Exp       Date:  2018-07-04       Impact factor: 1.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.